60% Mortality Drop: Pancreatic Cancer Breakthrough Exposes a Biotech Funding Crisis
TL;DR
* 60% Mortality Drop: Pancreatic Cancer Breakthrough Rewrites Biotech Rules — But U.S. Innovation Pipeline Faces a Crisis. Is the U.S. about to lose its biotech crown to China?
* Lululemon Stock Plunges 39% in a Week: Proxy War, CEO Swap, and Earnings Miss Spark Crisis. Can Lululemon recover
